• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AQST

AQST

Aquestive Therapeutics, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD4.03

+0.10 (+2.54%)

Rating:C

Company Profile

CEO

Daniel Barber

IPO Date

2018-07-25

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.90

Prev. Close

$3.93

Day Low

$3.85

Day High

$4.04

52W Low

$2.93

52W High

$7.55

Market Cap

$0.40B

Volume

1.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

24.1%

Avg Negative

2.3%

Avg Neutral

73.8%

News Feed

Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference

GlobeNewsWire·8/6/2021·↑ positive

Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/4/2021·↓ negative

Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance

GlobeNewsWire·8/3/2021·↑ positive

Earnings Preview: Aquestive Therapeutics (AQST) Q2 Earnings Expected to Decline

Zacks Investment Research·7/27/2021·↑ positive

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film

GlobeNewsWire·7/19/2021·↑ positive

Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film

GlobeNewsWire·6/24/2021·↑ positive

Aquestive Therapeutics: Bullish Outlook Continues To Harden

Seeking Alpha·6/23/2021·↑ positive

Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer

GlobeNewsWire·6/21/2021·↑ positive

Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences

GlobeNewsWire·6/9/2021·↑ positive

Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference

GlobeNewsWire·5/11/2021·↑ positive